HIMS
Hims Hers Health Inc
Hims Hers Health Inc historical holders
total: 2
Oaktree Capital Management Hims Hers Health Inc transactions over time
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 4
- Held since:
- 2021 Q1
- Held for:
- 15 quarters
- Latest activity:
- 2024 Q4
Howard Marks has been an institutional investor in Hims Hers Health Inc (HIMS) since 2021 Q1. According to 2026 Q2 report, Howard Marks doesn't hold any shares. The fund/company first acquired HIMS in 2021 Q1, initially purchasing about 3.77M shares. Since the initial investment, Oaktree Capital Management has made 5 more transactions in this position.
When did Howard Marks exit their HIMS position?
Howard Marks no longer holds Hims Hers Health Inc (HIMS). They sold off their entire position in 2024 Q4, closing out an investment that began in 2021 Q1.
When did Howard Marks first invest in HIMS?
Howard Marks first invested in Hims Hers Health Inc (HIMS) in 2021 Q1 at the reported quarter-end price of $13.23 per share, acquiring 3,773,437 shares in their initial purchase.
What is Howard Marks's average cost basis for HIMS?
Based on historical transaction data, Howard Marks's estimated cost basis for Hims Hers Health Inc (HIMS) is approximately $13.23 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $13.23
- Weighted AVG sell price:
- $11.34
HIMS transactions history by Oaktree Capital Management
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$18.42
|
|
-100% (-666,962)
|
-0.2%
|
|
2024 Q1
|
0.17%
|
666,962
|
$15.47
|
$10,317,902
|
-36.67% (-386,252)
|
-0.09%
|
|
2023 Q2
|
0.13%
|
1,053,214
|
$9.40
|
$9,900,211
|
-19.57% (-256,346)
|
-0.03%
|
|
2023 Q1
|
0.15%
|
1,309,560
|
$9.92
|
$12,990,835
|
-59.97% (-1,961,719)
|
-0.21%
|
|
2022 Q1
|
0.19%
|
3,271,279
|
$5.33
|
$17,436,000
|
-13.31% (-502,158)
|
-0.03%
|
|
2021 Q1
|
0.70%
|
3,773,437
|
$13.23
|
$49,923,000
|
new
|
+0.7%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.